252 related articles for article (PubMed ID: 10090348)
1. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
[TBL] [Abstract][Full Text] [Related]
2. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension.
White WB; Saunders E; Noveck RJ; Ferdinand K
Am J Hypertens; 2003 Sep; 16(9 Pt 1):739-45. PubMed ID: 12944032
[TBL] [Abstract][Full Text] [Related]
6. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
[TBL] [Abstract][Full Text] [Related]
7. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
[TBL] [Abstract][Full Text] [Related]
8. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.
Ruddy TD; Fodor JG
Cardiovasc Drugs Ther; 1997 Sep; 11(4):581-90. PubMed ID: 9358963
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension.
Lacourcière Y
Clin Ther; 2000 Oct; 22(10):1213-24. PubMed ID: 11110232
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
[TBL] [Abstract][Full Text] [Related]
11. Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial.
Skudicky D; Sareli P; Libhaber E; Candy G; Radevski I; Valtchanova Z; Tshele E; Thijs L; Wang JG; Staessen JA
Circulation; 2002 Feb; 105(7):830-6. PubMed ID: 11854123
[TBL] [Abstract][Full Text] [Related]
12. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
Zanchetti A; Omboni S
Am J Hypertens; 2001 Feb; 14(2):129-34. PubMed ID: 11243303
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
Estacio RO; Schrier RW
Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137
[TBL] [Abstract][Full Text] [Related]
14. Nisoldipine CC: clinical experience in hypertension.
Langan J; Rodríguez-Mañas L; Sareli P; Heinig R
Cardiology; 1997; 88 Suppl 1():56-62; discussion 63-5. PubMed ID: 9118169
[TBL] [Abstract][Full Text] [Related]
15. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
[TBL] [Abstract][Full Text] [Related]
17. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
Tarnow L; Sato A; Ali S; Rossing P; Nielsen FS; Parving HH
Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934
[TBL] [Abstract][Full Text] [Related]
18. What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?
Opie LH
Am J Cardiol; 1997 May; 79(10A):29-32; discussion 47-8. PubMed ID: 9186064
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic agents in the management of hypertension--nisoldipine coat-core.
White WB
J Clin Hypertens (Greenwich); 2007 Apr; 9(4):259-66. PubMed ID: 17396068
[TBL] [Abstract][Full Text] [Related]
20. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]